Celiac disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Malnutrition]] | [[Category:Malnutrition]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
Latest revision as of 20:50, 29 July 2020
Celiac disease Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Celiac disease cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Celiac disease cost-effectiveness of therapy |
Risk calculators and risk factors for Celiac disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: